Editorial:
The promise of dual targeting Akt/mTOR signaling in lethal prostate cancer
Metrics: PDF 2489 views | HTML 2028 views | ?
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 771